In particular, findings showing a positive correlation between IGF-1 levels and insulin resistance only in subjects without MetS, a predictive value of circulating IGF-1 for insulin levels, and a possible role of HDL-C in IGF-1 modulation could have important clinical implications for planning customized strategies aimed at modulating IGF-1 levels in BC survivors. Here, INS is linked to breast cancer.